• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cysteinylated Albumin as a Potential Biomarker for the Progression of Kidney Disease in Patients With Type 2 Diabetes.

作者信息

Imafuku Tadashi, Watanabe Hiroshi, Oniki Kentaro, Yoshida Akira, Kato Hiromasa, Nakano Takehiro, Tokumaru Kai, Fujita Issei, Arimura Nanaka, Maeda Hitoshi, Sakamoto Yuki, Kondo Nozomi, Morita Ayami, Saruwatari Junji, Tanaka Motoko, Matsushita Kazutaka, Wada Takashi, Fukagawa Masafumi, Otagiri Masaki, Fitzgerald Michael L, Jinnouchi Hideaki, Maruyama Toru

机构信息

Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.

Lipid Metabolism Unit, Center for Computational and Integrative Biology, Massachusetts General Hospital, Boston, MA.

出版信息

Diabetes Care. 2021 Jun;44(6):e115-e117. doi: 10.2337/dc20-3003. Epub 2021 Apr 26.

DOI:10.2337/dc20-3003
PMID:33905348
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8247487/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fe9/8247487/c2a67eeb845a/dc203003f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fe9/8247487/c2a67eeb845a/dc203003f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fe9/8247487/c2a67eeb845a/dc203003f1.jpg

相似文献

1
Cysteinylated Albumin as a Potential Biomarker for the Progression of Kidney Disease in Patients With Type 2 Diabetes.半胱氨酸化白蛋白作为2型糖尿病患者肾脏疾病进展的潜在生物标志物。
Diabetes Care. 2021 Jun;44(6):e115-e117. doi: 10.2337/dc20-3003. Epub 2021 Apr 26.
2
Plasma osteoprotegerin as a biomarker of poor glycaemic control that predicts progression of albuminuria in type 2 diabetes mellitus: A 3-year longitudinal cohort study.血浆骨保护素作为血糖控制不良的生物标志物，可预测 2 型糖尿病患者白蛋白尿的进展：一项为期 3 年的纵向队列研究。
Diabetes Res Clin Pract. 2020 Mar;161:107992. doi: 10.1016/j.diabres.2019.107992. Epub 2020 Feb 4.
3
Plasma Leucine-Rich α-2-Glycoprotein 1 Predicts Rapid eGFR Decline and Albuminuria Progression in Type 2 Diabetes Mellitus.血浆亮氨酸丰富α-2-糖蛋白 1 可预测 2 型糖尿病患者的 eGFR 快速下降和蛋白尿进展。
J Clin Endocrinol Metab. 2017 Oct 1;102(10):3683-3691. doi: 10.1210/jc.2017-00930.
4
Profibrotic Circulating Proteins and Risk of Early Progressive Renal Decline in Patients With Type 2 Diabetes With and Without Albuminuria.有和无白蛋白尿的2型糖尿病患者中促纤维化循环蛋白与早期进行性肾衰退风险
Diabetes Care. 2020 Nov;43(11):2760-2767. doi: 10.2337/dc20-0630. Epub 2020 Sep 4.
5
[Preventing diabetic nephropathy significantly].显著预防糖尿病肾病
Praxis (Bern 1994). 2013 Oct 2;102(20):1215. doi: 10.1024/1661-8157/a001446.
6
Systolic blood pressure as a predictor of incident albuminuria and rapid renal function decline in type 2 diabetic patients.收缩压作为2型糖尿病患者发生蛋白尿和肾功能快速下降的预测指标。
J Diabetes Complications. 2014 Nov-Dec;28(6):779-84. doi: 10.1016/j.jdiacomp.2014.08.002. Epub 2014 Aug 16.
7
Novel biomarkers of diabetic kidney disease: current status and potential clinical application.糖尿病肾病的新型生物标志物：现状与潜在临床应用。
Acta Diabetol. 2021 Jul;58(7):819-830. doi: 10.1007/s00592-020-01656-9. Epub 2021 Feb 2.
8
Does microalbuminuria predict diabetic nephropathy?微量白蛋白尿能否预测糖尿病肾病？
Diabetes Care. 2002 Feb;25(2):406-7. doi: 10.2337/diacare.25.2.406.
9
Clinical update: The important role of dual kidney function testing (ACR and eGFR) in primary care: Identification of risk and management in type 2 diabetes.临床更新：双肾功能检测（ACR 和 eGFR）在初级保健中的重要作用：2 型糖尿病的风险识别和管理。
Prim Care Diabetes. 2020 Aug;14(4):370-375. doi: 10.1016/j.pcd.2020.02.006. Epub 2020 Mar 2.
10
Biomarkers of diabetic kidney disease.糖尿病肾病的生物标志物。
Diabetologia. 2018 May;61(5):996-1011. doi: 10.1007/s00125-018-4567-5. Epub 2018 Mar 8.

引用本文的文献

1
The Influence of Diabetes Mellitus and Kidney Dysfunction on Oxidative Stress, a Reflection of the Multisystem Interactions in Aortic Stenosis.糖尿病和肾功能不全对氧化应激的影响，主动脉瓣狭窄多系统相互作用的一种反映
Antioxidants (Basel). 2025 Jul 18;14(7):888. doi: 10.3390/antiox14070888.
2
Efficacy of Nrf2 activation in a proteinuric Alport syndrome mouse model.Nrf2激活在蛋白尿性奥尔波特综合征小鼠模型中的疗效
Life Sci Alliance. 2025 Jun 17;8(8). doi: 10.26508/lsa.202503330. Print 2025 Aug.
3
Exploratory Analysis of Serum Oxidized Albumin as a Potential Prognostic Indicator for Diabetic Microvascular Complications: A Retrospective Cohort Pilot Study.
血清氧化型白蛋白作为糖尿病微血管并发症潜在预后指标的探索性分析：一项回顾性队列初步研究。
Cureus. 2025 May 12;17(5):e83976. doi: 10.7759/cureus.83976. eCollection 2025 May.
4
Association between Albumin Alterations and Renal Function in Patients with Type 2 Diabetes Mellitus.白蛋白改变与 2 型糖尿病患者肾功能的关系。
Int J Mol Sci. 2024 Mar 9;25(6):3168. doi: 10.3390/ijms25063168.
5
Impaired Cholesterol Efflux Capacity rather than Low HDL-C Reflects Oxidative Stress under Acute Myocardial Infarction.急性心肌梗死时，胆固醇外排能力受损而非 HDL-C 降低反映氧化应激。
J Atheroscler Thromb. 2024 Aug 1;31(8):1149-1161. doi: 10.5551/jat.64691. Epub 2024 Feb 20.
6
Albumin of People with Diabetes Mellitus Is More Reduced at Low HbA1c.糖尿病患者的白蛋白在较低的 HbA1c 时降低更明显。
Int J Mol Sci. 2023 Nov 13;24(22):16256. doi: 10.3390/ijms242216256.
7
A simple colorimetric assay to determine the concentration and proportion of human mercaptalbumin.一种用于测定人巯基白蛋白浓度和比例的简单比色测定法。
Pract Lab Med. 2022 May 23;31:e00281. doi: 10.1016/j.plabm.2022.e00281. eCollection 2022 Aug.
8
Recent advances in nephropathy biomarker detections using paper-based analytical devices.近年来，基于纸基分析器件的肾病生物标志物检测技术取得了新进展。
Anal Sci. 2022 Jan;38(1):39-54. doi: 10.2116/analsci.21SAR10. Epub 2022 Feb 28.
9
Additive Effects of Drinking Habits and a Susceptible Genetic Polymorphism on Cholesterol Efflux Capacity.饮酒习惯与易感性基因多态性对胆固醇流出能力的累加效应。
J Atheroscler Thromb. 2023 Jan 1;30(1):23-38. doi: 10.5551/jat.63277. Epub 2022 Mar 4.
10
Predictive Ability of Visit-to-Visit Variability of HbA1c Measurements for the Development of Diabetic Kidney Disease: A Retrospective Longitudinal Observational Study.HbA1c 测量的 Visit-to-Visit 变异性对糖尿病肾病发展的预测能力：一项回顾性纵向观察研究。
J Diabetes Res. 2022 Jan 22;2022:6934188. doi: 10.1155/2022/6934188. eCollection 2022.